Z-1069-2018 Class II Terminated

Recalled by Diagnostica Stago, Inc. — Parsippany, NJ

FDA device recall Z-1069-2018 was initiated by Diagnostica Stago, Inc. on Oct 25, 2017 and is designated Class II. Reason for recall: Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%). The recall status is terminated (terminated May 12, 2020).

Recall details

Product Type
Devices
Report Date
Mar 21, 2018
Initiation Date
Oct 25, 2017
Termination Date
May 12, 2020
Voluntary/Mandated
Voluntary: Firm initiated

Product description

STA - Neoplastine¿ Cl Plus ¿ (ref. 00606) Product Usage: Manual or automated determination of the prothrombin time (PT).

Reason for recall

Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).

Distribution pattern

Nationally

Code information

Lot: 250041RX (Exp: 2018-02) Lot: 250077 (Exp: 2018-02) Lot: 250246RU (Exp: 2018-03) Lot: 251492 (Exp: 2018-09) Lot: 251308 (Exp: 2018-10) Lot: 251626 (Exp: 20 19-01) Lot: 251730 (Exp: 2019-02) Lot: 251772 (Exp: 2019-02)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1069-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1069-2018. Report a data issue: hello@regdatalab.com.